Aggregate carrying amount of current liabilities (due within one year or within the normal operating cycle if longer) not separately disclosed in the balance sheet. Includes costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered and of liabilities not separately disclosed.

+ References+ Details

The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.

+ References+ Details

Intangible Assets - Intellectual Property (Details Narrative) (USD $)	3 Months Ended		9 Months Ended				3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013	Sep. 30, 2014 Dr. Gerlach [Member]	Mar. 31, 2014 Series A Warrant [Member]	Sep. 30, 2013 Series A Warrant [Member]	Sep. 30, 2014 Series A Warrant [Member]	Sep. 30, 2013 Series A Warrant [Member]
Other current liabilities	$ 137,500		$ 137,500			$ 100,000
Other long term liabilities						200,000
Consulting expense							115,840	54,668	311,173	54,668
Research and development expense	$ 902,219		$ 956,719				$ 537,217		$ 537,217